0001516587-11-000003.txt : 20110405 0001516587-11-000003.hdr.sgml : 20110405 20110405110703 ACCESSION NUMBER: 0001516587-11-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110405 DATE AS OF CHANGE: 20110405 EFFECTIVENESS DATE: 20110405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORAYA THERAPEUTICS INC CENTRAL INDEX KEY: 0001395387 IRS NUMBER: 205114559 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-152645 FILM NUMBER: 11738533 BUSINESS ADDRESS: STREET 1: 8000 JARVIS AVENUE CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 5104563702 MAIL ADDRESS: STREET 1: 8000 JARVIS AVENUE CITY: NEWARK STATE: CA ZIP: 94560 D/A 1 primary_doc.xml X0704 D/A LIVE 0001395387 ORAYA THERAPEUTICS INC 8000 JARVIS AVENUE NEWARK CA CALIFORNIA 94560 5104563702 DELAWARE GEM Biosystems, Inc. None Corporation true 2006 Michael Gertner 8000 Jarvis Avenue Building 5 Newark CA CALIFORNIA 94560 Director Mark Brooks 8000 Jarvis Avenue Building 5 Newark CA CALIFORNIA 94560 Director John Onopchenko 8000 Jarvis Avenue Building 5 Newark CA CALIFORNIA 94560 Director Reza Zadno 8000 Jarvis Avenue Building 5 Newark CA CALIFORNIA 94560 Director James Taylor 8000 Jarvis Avenue Building 5 Newark CA CALIFORNIA 94560 Executive Officer Director Brian Halak 8000 Jarvis Avenue Building 5 Newark CA CALIFORNIA 94560 Director Peter Cohn 1000 Marsh Road Menlo Park CA CALIFORNIA 94025 Executive Officer Other Technology Decline to Disclose 06 true 0001395387-10-000002 2010-12-15 false true true Series C Preferred Stock false 0 20875000 20875000 0 The actual Total Offering Amount and Total Amount Sold was $20,874,999.77. false 7 0 0 0 false ORAYA THERAPEUTICS INC Peter Cohn Peter Cohn Secretary 2011-04-05